NCT03389373

Brief Summary

Specific Aims 1\) Assess CG (Cariogenic) Saliva-Check Mutans® saliva testing for identification of high caries risk patients

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 3, 2018

Completed
29 days until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

July 16, 2018

Status Verified

July 1, 2018

Enrollment Period

5 months

First QC Date

December 22, 2017

Last Update Submit

July 12, 2018

Conditions

Keywords

Dental Caries

Outcome Measures

Primary Outcomes (1)

  • Count of Strep Mutans bacterial

    Bacterial (MS) samples resulting in〖5x10〗\^5 colony-forming units per milliliter of saliva (CFU/mL) indicates a low caries risk. In contrast, \>〖5x10〗\^5 CFU/mL of MS in a saliva sample correlates to a moderate or high caries risk. This study is designed to use saliva sampling to determine a non-surgical adjunctive therapy to help lower cavity causing bacteria.

    4 weeks

Secondary Outcomes (1)

  • Plaque Index

    4 weeks

Study Arms (1)

Child with full primary dentition

OTHER

All children who match inclusion criteria are eligible to have a saliva sample obtained which will act as a proxy for bacterial levels. High bacteria levels are correlated with a higher risk of developing cavities.

Device: GC Strep Mutans Saliva Sampling

Interventions

Children who match inclusion criteria will have a saliva sample obtained which will act as a proxy for bacterial levels.

Child with full primary dentition

Eligibility Criteria

Age24 Months - 96 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Subjects must be a patient of record at Children's Hospital Colorado Dental Center
  • Child must fall between 24 and 96 months of age
  • Child must present with full primary dentition

You may not qualify if:

  • Patients with a complex medical history classified as being greater than ASA II
  • Patients with recent dose of antibiotics within the previous two weeks or who present with a low caries risk set forth by the AAPD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children'S Hospital Colorado Dental Center

Aurora, Colorado, 80045, United States

Location

Related Publications (9)

  • Dye BA, Li X, Beltran-Aguilar ED. Selected oral health indicators in the United States, 2005-2008. NCHS Data Brief. 2012 May;(96):1-8.

  • Larson K, Cull WL, Racine AD, Olson LM. Trends in Access to Health Care Services for US Children: 2000-2014. Pediatrics. 2016 Dec;138(6):e20162176. doi: 10.1542/peds.2016-2176. Epub 2016 Nov 15.

  • Mills C, Patel P. Adopting caries risk assessment in all practice environments. Gen Dent. 2016 Jul-Aug;64(4):66-72.

  • Edelstein BL, Ureles SD, Smaldone A. Very High Salivary Streptococcus Mutans Predicts Caries Progression in Young Children. Pediatr Dent. 2016;38(4):325-30.

  • Li Y, Argimon S, Schon CN, Saraithong P, Caufield PW. Characterizing Diversity of Lactobacilli Associated with Severe Early Childhood Caries: A Study Protocol. Adv Microbiol. 2015 Jan 1;5(1):9-20. doi: 10.4236/aim.2015.51002.

  • Leone CW, Oppenheim FG. Physical and chemical aspects of saliva as indicators of risk for dental caries in humans. J Dent Educ. 2001 Oct;65(10):1054-62.

  • Thibodeau EA, O'Sullivan DM, Tinanoff N. Mutans streptococci and caries prevalence in preschool children. Community Dent Oral Epidemiol. 1993 Oct;21(5):288-91. doi: 10.1111/j.1600-0528.1993.tb00776.x.

  • Lee C, Tinanoff N, Minah G, Romberg E. Effect of Mutans streptococcal colonization on plaque formation and regrowth in young children--a brief commnunication. J Public Health Dent. 2008 Winter;68(1):57-60. doi: 10.1111/j.1752-7325.2007.00050.x.

  • Amaechi BT, Ramalingam K, Mensinkai PK, Chedjieu I. In situ remineralization of early caries by a new high-fluoride dentifrice. Gen Dent. 2012 Jul-Aug;60(4):e186-92.

Related Links

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Officials

  • Camille V Gannam, DMD MS

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Provider and investigator will know if child has clinical caries or not at the time of saliva sample.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Children will have a saliva sample analyzed for amount of bacteria. Children who have higher bacteria counts are at higher risk of developing cavities.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2017

First Posted

January 3, 2018

Study Start

February 1, 2018

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

July 16, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

This is a small resident research project comparing the effect of Prevident5000 plus versus over the counter toothpaste on cariogenic bacteria counts as well as the effect of frequent hygiene reminders on oral hygiene (plaque score).

Locations